Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.01
(1.01%)
CNY 7.01
(1.01%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -89.9 Million CNY | 22.05% |
| 2022 | -115.34 Million CNY | 16.66% |
| 2021 | -138.4 Million CNY | -130.83% |
| 2020 | 448.9 Million CNY | 19.24% |
| 2019 | 376.46 Million CNY | 13054.83% |
| 2018 | 2.86 Million CNY | -96.58% |
| 2017 | 83.67 Million CNY | 213.87% |
| 2016 | -73.48 Million CNY | 76.74% |
| 2015 | -315.85 Million CNY | -18.42% |
| 2014 | -266.72 Million CNY | 2.68% |
| 2013 | -274.07 Million CNY | -14.94% |
| 2012 | -238.44 Million CNY | -17.82% |
| 2011 | -202.37 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -16.61 Million CNY | -151.51% |
| 2024 Q1 | 10.05 Million CNY | 111.19% |
| 2024 Q2 | 24.34 Million CNY | 142.04% |
| 2023 Q3 | -127.47 Million CNY | 53.53% |
| 2023 Q2 | -274.34 Million CNY | -585.53% |
| 2023 FY | -89.9 Million CNY | 22.05% |
| 2023 Q4 | -89.9 Million CNY | 29.47% |
| 2023 Q1 | -40.01 Million CNY | 65.3% |
| 2022 Q4 | -115.34 Million CNY | -5.22% |
| 2022 Q3 | -109.62 Million CNY | -22.49% |
| 2022 Q1 | -37.88 Million CNY | 72.63% |
| 2022 FY | -115.34 Million CNY | 16.66% |
| 2022 Q2 | -89.49 Million CNY | -136.21% |
| 2021 Q2 | 365.87 Million CNY | -28.9% |
| 2021 Q4 | -138.4 Million CNY | -1650.22% |
| 2021 FY | -138.4 Million CNY | -130.83% |
| 2021 Q1 | 514.59 Million CNY | 14.63% |
| 2021 Q3 | -7.9 Million CNY | -102.16% |
| 2020 Q1 | 544.7 Million CNY | 44.69% |
| 2020 Q2 | 427.88 Million CNY | -21.45% |
| 2020 Q4 | 448.9 Million CNY | -14.99% |
| 2020 FY | 448.9 Million CNY | 19.24% |
| 2020 Q3 | 528.04 Million CNY | 23.41% |
| 2019 Q3 | -33.96 Million CNY | 52.62% |
| 2019 FY | 376.46 Million CNY | 13054.83% |
| 2019 Q4 | 376.46 Million CNY | 1208.42% |
| 2019 Q1 | 25.59 Million CNY | 794.45% |
| 2019 Q2 | -71.68 Million CNY | -380.04% |
| 2018 Q1 | 2 Million CNY | -97.6% |
| 2018 FY | 2.86 Million CNY | -96.58% |
| 2018 Q4 | 2.86 Million CNY | -79.43% |
| 2018 Q3 | 13.91 Million CNY | -76.58% |
| 2018 Q2 | 59.4 Million CNY | 2860.58% |
| 2017 Q4 | 83.67 Million CNY | -3.37% |
| 2017 FY | 83.67 Million CNY | 213.87% |
| 2017 Q1 | -381.65 Million CNY | -419.38% |
| 2017 Q2 | 49.58 Million CNY | 112.99% |
| 2017 Q3 | 86.59 Million CNY | 74.64% |
| 2016 Q4 | -73.48 Million CNY | 37.04% |
| 2016 Q2 | -150.42 Million CNY | 59.67% |
| 2016 Q1 | -372.94 Million CNY | -18.08% |
| 2016 Q3 | -116.71 Million CNY | 22.4% |
| 2016 FY | -73.48 Million CNY | 76.74% |
| 2015 Q3 | -580.5 Million CNY | 0.07% |
| 2015 Q1 | -232.52 Million CNY | 12.82% |
| 2015 FY | -315.85 Million CNY | -18.42% |
| 2015 Q4 | -315.85 Million CNY | 45.59% |
| 2015 Q2 | -580.91 Million CNY | -149.83% |
| 2014 FY | -266.72 Million CNY | 2.68% |
| 2014 Q1 | 274.07 Million CNY | 0.0% |
| 2014 Q4 | -266.72 Million CNY | 0.0% |
| 2013 FY | -274.07 Million CNY | -14.94% |
| 2012 FY | -238.44 Million CNY | -17.82% |
| 2011 FY | -202.37 Million CNY | 0.0% |